ProfileGDS5822 / ILMN_2758969
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 75% 69% 65% 77% 70% 65% 74% 80% 75% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 177.575
GSM1276600PDAC Late Ablation Control 249.969
GSM1276601PDAC Late Ablation Control 347.465
GSM1276602PDAC Late Ablation 196.377
GSM1276603PDAC Late Ablation 257.870
GSM1276604PDAC Late Ablation 342.365
GSM1303940PDAC Late Ablation_anti-CTLA4 171.774
GSM1303941PDAC Late Ablation_anti-CTLA4 2192.680
GSM1303942PDAC Late Ablation_anti-CTLA4 3106.975